BR0215719A - Proteìnas com domìnios bacterianos repetitivos semelhantes a ig (big) presentes em espécies de leptospira - Google Patents

Proteìnas com domìnios bacterianos repetitivos semelhantes a ig (big) presentes em espécies de leptospira

Info

Publication number
BR0215719A
BR0215719A BR0215719-5A BR0215719A BR0215719A BR 0215719 A BR0215719 A BR 0215719A BR 0215719 A BR0215719 A BR 0215719A BR 0215719 A BR0215719 A BR 0215719A
Authority
BR
Brazil
Prior art keywords
proteins
big
present
leptospira species
repetitive
Prior art date
Application number
BR0215719-5A
Other languages
English (en)
Inventor
Albert I Ko
Mitermayer Galvao Reis
Julio Henrique Rosa Croda
Isadora Cristina Siqueira
David A Haake
James Matsunaga
Lee W Riley
Michele Barocchi
Tracy Ann Young
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Priority claimed from PCT/BR2002/000072 external-priority patent/WO2003098214A1/en
Publication of BR0215719A publication Critical patent/BR0215719A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1207—Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)

Abstract

"PROTEìNAS COM DOMìNIOS BACTERIANOS REPETITIVOS SEMELHANTES A Ig (Big) PRESENTES EM ESPéCIES DE LEPTOSPIRA". A invenção esta relacionada a três moléculas isoladas de DNA que codificam para proteínas, BigL1, BigL2 e BigL3, nas bactérias da Leptospira sp que possuem domínios bacterianos do tipo Ig repetitivos (big) e o seu uso em diagnóstico; aplicações terapêuticas e vacina. Segundo esta invenção, as moléculas isoladas que codificam as proteínas BigL1, BigL2 e BigL3 são utilizadas para diagnóstico e prevenção de infecção com espécies de Leptospira, que são capazes de produzir doenças em seres humanos e outros mamíferos, inclusive aqueles de importância veterinária.
BR0215719-5A 2002-05-17 2002-05-20 Proteìnas com domìnios bacterianos repetitivos semelhantes a ig (big) presentes em espécies de leptospira BR0215719A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/147,299 US20040058323A1 (en) 2002-05-17 2002-05-17 Proteins with repetitive bacterial-Ig-like (big) domains present in leptospira species
PCT/BR2002/000072 WO2003098214A1 (en) 2002-05-17 2002-05-20 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species

Publications (1)

Publication Number Publication Date
BR0215719A true BR0215719A (pt) 2005-10-04

Family

ID=31990111

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215719-5A BR0215719A (pt) 2002-05-17 2002-05-20 Proteìnas com domìnios bacterianos repetitivos semelhantes a ig (big) presentes em espécies de leptospira

Country Status (8)

Country Link
US (13) US20040058323A1 (pt)
JP (1) JP2006516083A (pt)
CN (1) CN1639570A (pt)
AR (1) AR039035A1 (pt)
AT (1) ATE374943T1 (pt)
BR (1) BR0215719A (pt)
ES (1) ES2295464T3 (pt)
NZ (1) NZ537326A (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2820949C (en) 2002-10-10 2015-12-08 Cornell Research Foundation, Inc. Novel immunogenic proteins of leptospira
KR100760525B1 (ko) * 2006-04-13 2007-10-04 김재만 병원성 미생물의 무증폭 다중 정량 검출킷트 및 검출방법
BR112015013846A2 (pt) 2012-12-12 2017-08-22 The Regents Of The Univ Of California Immport Therapeutics Inc E Yale Univ Composição de antígeno
KR101755231B1 (ko) 2015-06-30 2017-07-10 부산대학교 산학협력단 토마토 근부위조병 저항성 유전자 선발용 분자마커

Also Published As

Publication number Publication date
ATE374943T1 (de) 2007-10-15
US9133250B2 (en) 2015-09-15
US8021673B2 (en) 2011-09-20
US7935357B2 (en) 2011-05-03
US8802835B2 (en) 2014-08-12
CN1639570A (zh) 2005-07-13
US20110311570A1 (en) 2011-12-22
US8216594B2 (en) 2012-07-10
US20130230903A1 (en) 2013-09-05
US9505809B2 (en) 2016-11-29
US9932391B2 (en) 2018-04-03
US20120121639A1 (en) 2012-05-17
US20150329599A1 (en) 2015-11-19
ES2295464T3 (es) 2008-04-16
AR039035A1 (es) 2005-02-02
US20180186867A1 (en) 2018-07-05
US8124110B2 (en) 2012-02-28
US20170037114A1 (en) 2017-02-09
US7718183B2 (en) 2010-05-18
US20070110764A1 (en) 2007-05-17
US20140308734A1 (en) 2014-10-16
NZ537326A (en) 2008-04-30
US20110182924A1 (en) 2011-07-28
US9346858B2 (en) 2016-05-24
JP2006516083A (ja) 2006-06-22
US20040058323A1 (en) 2004-03-25
US20100183656A1 (en) 2010-07-22
US20160222069A1 (en) 2016-08-04
US8445658B2 (en) 2013-05-21
US20120270301A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
UY26783A1 (es) Antígenos de estreptococo.
BRPI0410041A (pt) métodos para tratamento de dor de cabeça de sinusite
BR112022022524A2 (pt) Proteínas imunomoduladoras inibidoras de april e baff com e sem uma proteína inibidora de células t e métodos de uso das mesmas
BR112022022456A2 (pt) Proteínas de ligação de repetição de anquirina e seus usos
BR0114105A (pt) Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas
ATE309271T1 (de) Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen
BR9909483A (pt) Derivados de proteìnas ligantes pneumococcal colina para vacinas
BR0110975A (pt) Tratamento profilático e terapêutico de doenças infecciosas ou outras doenças com compostos à base de mono- e disacarìdeos
BR112013010844A2 (pt) nova endolisina
BR0016709A (pt) Agente antiadesão da flora patogênica da pele
BRPI1010830A2 (pt) Sequências de aminoácidos melhoradas direcionadas contra o vírus respiratório sencicial humano (hrsv) e polipetídeos que compreende os mesmos para prevenção e/ou tratamento de infecções do trato respiratório.
BRPI0315228A8 (pt) Vacinas de polipeptídeo para ampla proteção contra linhagens meningocócicas hipervirulentas
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
BR9809914A (pt) Genes de moracella receptores de lactoferrina
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
BRPI0407533A (pt) proteìnas de fusão e muteìnas do interferon alfa com propriedades melhoradas
PT750672E (pt) Sequencias de adn para metaloproteases matriciais, sua preparacao e utilizacao.
MX2022012647A (es) Composiciones que comprenden tres proteinas de fusion de ospa para uso medico.
BR0006291A (pt) Bactéria do gênero salmonella, vacina para aproteção de animais contra a salmonelose, uso deuma bactéria, e, processo para a preparação deuma vacina
ATE291586T1 (de) Humanes antibiotisches protein
BR0112131A (pt) Composições farmacêuticas e métodos para uso
AR039035A1 (es) Proteinas con dominios tipo ig bacterianos (big) presentes en especies de leptospira
BR9814958B1 (pt) Proteína de cimento de tecido, composição farmacêutica, uso da proteína de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido
BR0309412A (pt) Indol-2-onas como inibidores seletivos da ciclooxigenase-2
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: APRESENTE O DEPOSITANTE TRADUCAO COMPLETA DO PEDIDO, CONFORME DETERMINA O ATO NORMATIVO N 128 DE 19970305, ITENS 9.2 E 9.2.1

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B04C Request for examination: application reinstated [chapter 4.3 patent gazette]
B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR 6A ANUIDADE DE ACORDO COM TABELA VIGENTE, REFERENTE A GUIA 220705785553.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2138 DE 27/12/2011.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 25 E 10 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]